Bladder Cancer Trends in Latvia During 1990-2017: Incidence, Mortality, and Survival Rates

Overview

Journal Cent European J Urol

Specialty Urology

Date 2021 May 12

PMID 33976911

Citations 1

Authors

erika Bitina-Barlote

Juris Plonis

Vinita Cauce

Egils Vjaters

Janis Gardovskis

Edvins Miklasevics

Miki Nakazawa-Miklasevica

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of this article was to evaluate bladder cancer (BC) incidence, mortality and survival trends in Latvia over the past 28 years.

Material And Methods: Our study included patients diagnosed with BC between 1990 and 2017. The data were obtained from the national population-based cancer registry. Joinpoint regression analysis was used to identify points where a significant change in incidence and mortality trends occurred, accordingly with the patient's gender and age. Relative survival (RS) was estimated by Ederer I and II methods.

Results: Altogether, 9589 patients with initial BC diagnosis were included in the study. The age-standardised (ASR) incidence rates (per 100,000) increased from 6.8 in 1990 to 12.5 in 2014 followed by a statistically insignificant decrease continuing up to 2017. The ASR BC mortality rates (per 100,000) also rose from 3.9 in 1990 to 4.4 in 2017. However, there was a decline in BC mortality trends in the age-group 40-59 with annual percentage change (APC) -1.1%. RS rates increased from 55.0 % in 1990-2000 to 59.0% in years 2013-2017.

Conclusions: This study revealed that the incidence and mortality rates have been gradually increasing over the past 28 years. The exception being cancer-specific mortality in the age group 40-59, which tends to decrease. Although the 5-year RS rates improved over the reviewed period, there is still plenty of room for improvement.

Citing Articles

ARSENIC IN DRINKING WATER AND URINE AND ITS RELATIONSHIP WITH MALIGNANT TUMORS OF URINARY TRACT IN OSIJEK-BARANJA COUNTY, CROATIA.

Vidosavljevic M, Puntaric D, Gvozdic V, Vidosavljevic D, Sijanovic S, Sekerija M Acta Clin Croat. 2024; 62(Suppl2):95-103.

PMID: 38966031 PMC: 11221220. DOI: 10.20471/acc.2023.62.s2.13.

References

Noon A, Albertsen P, Thomas F, Rosario D, Catto J . Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer. 2013; 108(7):1534-40. PMC: 3629420. DOI: 10.1038/bjc.2013.106. View

Williams S, Huo J, Chamie K, Hu J, Giordano S, Hoffman K . Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Eur Urol Focus. 2017; 3(2-3):258-264. DOI: 10.1016/j.euf.2016.04.008. View

Silverman D, Levin L, Hoover R . Occupational risks of bladder cancer among white women in the United States. Am J Epidemiol. 1990; 132(3):453-61. DOI: 10.1093/oxfordjournals.aje.a115680. View

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

Shariat S, Sfakianos J, Droller M, Karakiewicz P, Meryn S, Bochner B . The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2009; 105(3):300-8. PMC: 4315315. DOI: 10.1111/j.1464-410X.2009.09076.x. View

Leon D . Trends in European life expectancy: a salutary view. Int J Epidemiol. 2011; 40(2):271-7. DOI: 10.1093/ije/dyr061. View

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F . Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2016; 71(1):96-108. DOI: 10.1016/j.eururo.2016.06.010. View

Krilaviciute A, Smailyte G, Brenner H, Gondos A . Cancer survival in Lithuania after the restoration of independence: rapid improvements, but persisting major gaps. Acta Oncol. 2014; 53(9):1238-44. DOI: 10.3109/0284186X.2014.888495. View

Cheng L, NEUMANN R, Scherer B, Weaver A, Leibovich B, Nehra A . Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer. 1999; 85(12):2638-47. DOI: 10.1002/(sici)1097-0142(19990615)85:12<2638::aid-cncr21>3.0.co;2-v. View

10.

Gunlusoy B, Ceylan Y, Degirmenci T, Kozacioglu Z, Yonguc T, Bozkurt H . Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour. Can Urol Assoc J. 2015; 9(9-10):E727-30. PMC: 4662444. DOI: 10.5489/cuaj.3049. View

11.

Gore J, Litwin M, Lai J, Yano E, Madison R, Setodji C . Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst. 2010; 102(11):802-11. PMC: 3245689. DOI: 10.1093/jnci/djq121. View

12.

Scosyrev E, Noyes K, Feng C, Messing E . Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2008; 115(1):68-74. DOI: 10.1002/cncr.23986. View

13.

Fitzpatrick J, Reda M . Bladder carcinoma in patients 40 years old or less. J Urol. 1986; 135(1):53-4. DOI: 10.1016/s0022-5347(17)45513-3. View

14.

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M . Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103:356-387. DOI: 10.1016/j.ejca.2018.07.005. View

15.

Chalasani V, Chin J, Izawa J . Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J. 2009; 3(6 Suppl 4):S193-8. PMC: 2792446. DOI: 10.5489/cuaj.1195. View

16.

Hinotsu S, Akaza H, Miki T, Fujimoto H, Shinohara N, Kikuchi E . Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association. Int J Urol. 2008; 16(1):64-9. DOI: 10.1111/j.1442-2042.2008.02194.x. View

17.

Brenner H, Stegmaier C, Ziegler H . Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol. 2005; 16(6):981-6. DOI: 10.1093/annonc/mdi186. View

18.

Hemelt M, Yamamoto H, Cheng K, Zeegers M . The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer. 2008; 124(2):412-9. DOI: 10.1002/ijc.23856. View

19.

Wong M, Fung F, Leung C, Cheung W, Goggins W, Ng C . The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018; 8(1):1129. PMC: 5773684. DOI: 10.1038/s41598-018-19199-z. View

20.

Dy G, Gore J, Forouzanfar M, Naghavi M, Fitzmaurice C . Global Burden of Urologic Cancers, 1990-2013. Eur Urol. 2016; 71(3):437-446. DOI: 10.1016/j.eururo.2016.10.008. View